Clinical characteristics that impact onabotulinumtoxinA treatment adherence in patients with spasticity from ASPIRE

M Fredericks; A Esquenazi; W Feng; GF Wittenberg; P Gallien; Alessio BARICICH; K Fanning; A Zuzek; GE Francisco; DS Bandari

Clinical characteristics that impact onabotulinumtoxinA treatment adherence in patients with spasticity from ASPIRE

M Fredericks
, A Esquenazi
, W Feng
, GF Wittenberg
, P Gallien
, Alessio BARICICH
, K Fanning
, A Zuzek
, GE Francisco
, DS Bandari

Department of Health Sciences

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Pages	52-52
Number of pages	1
Publication status	Published - 2019

Access to Document

http://hdl.handle.net/11579/112435

Cite this

@conference{2404dfdb08cb4e4896a1514107bd80fd,

title = "Clinical characteristics that impact onabotulinumtoxinA treatment adherence in patients with spasticity from ASPIRE",

author = "M Fredericks and A Esquenazi and W Feng and GF Wittenberg and P Gallien and Alessio BARICICH and K Fanning and A Zuzek and GE Francisco and DS Bandari",

year = "2019",

language = "English",

pages = "52--52",

}

TY - CONF

T1 - Clinical characteristics that impact onabotulinumtoxinA treatment adherence in patients with spasticity from ASPIRE

AU - Fredericks, M

AU - Esquenazi, A

AU - Feng, W

AU - Wittenberg, GF

AU - Gallien, P

AU - BARICICH, Alessio

AU - Fanning, K

AU - Zuzek, A

AU - Francisco, GE

AU - Bandari, DS

PY - 2019

Y1 - 2019

UR - https://iris.uniupo.it/handle/11579/112435

M3 - Abstract

SP - 52

EP - 52

ER -

Clinical characteristics that impact onabotulinumtoxinA treatment adherence in patients with spasticity from ASPIRE

Access to Document

Other files and links

Cite this